Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation
- PMID: 15839723
- DOI: 10.2165/00002512-200522040-00007
Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation
Abstract
Background and objective: Atrial fibrillation is an indication for oral anticoagulation treatment. Maintaining the International Normalized Ratio (INR) within the therapeutic range minimises thromboembolic and bleeding complications. We have investigated whether cognitive capacity affects control of anticoagulation in elderly patients with atrial fibrillation.
Patients and methods: A retrospective study was conducted to investigate the association between cognitive impairment and control of anticoagulation. Patients > or =70 years of age with atrial fibrillation using acenocoumarol (nicoumalone) as anticoagulant were included. All patients were monitored by the Anticoagulation Clinic in the Midden-Brabant region in the Netherlands. The cognitive function of all patients was assessed using the Mini-Mental State Examination (MMSE) on the index date. INR values were obtained from the year preceding the index date. Patients with an MMSE score <23 were defined as cognitively impaired. The primary outcome of the study was the incidence of an INR value within the therapeutic range of 2.0-3.4 during < or =70% of treatment time in the year prior to the cognitive function assessment. The secondary endpoint was the number of patients with an INR <2.0 or > or =6.0 at least once during this year. Logistic regression analysis was used to evaluate the association between cognitive function and control of anticoagulation.
Results: A total of 152 patients were included in the study. An MMSE score <23 was associated with an inadequate INR control (odds ratio [OR] 2.77; 95% CI 1.13, 6.74). After correction for hospital admission and change of possibly interacting medication (both also associated with inadequate INR control), this association remained statistically significant. Significantly more patients with an MMSE score <23 had one or more INR values of six or higher (OR 3.06; 95% CI 1.14, 8.18).
Conclusion: In elderly people with atrial fibrillation using oral anticoagulation, an MMSE score <23 is independently associated with an inadequate INR control, mainly because of an increased number of supratherapeutic INR values. This finding should be taken into account when making decisions about use of oral anticoagulants in the elderly.
Similar articles
-
[Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].Pol Merkur Lekarski. 2014 May;36(215):302-6. Pol Merkur Lekarski. 2014. PMID: 24964505 Clinical Trial. Polish.
-
Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.Pol Arch Med Wewn. 2016 Aug 9;126(7-8):494-501. doi: 10.20452/pamw.3475. Epub 2016 Aug 9. Pol Arch Med Wewn. 2016. PMID: 27511466
-
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.Am J Med. 2015 Nov;128(11):1237-43. doi: 10.1016/j.amjmed.2015.05.036. Epub 2015 Jun 15. Am J Med. 2015. PMID: 26087049
-
[Anticoagulation with atrial fibrillation].Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):89-94. doi: 10.1007/s00399-006-0515-z. Herzschrittmacherther Elektrophysiol. 2006. PMID: 16786467 Review. German.
-
[Oral anticoagulation in the elderly - practical aspects and risk-benefit trade-off in atrial fibrillation].Praxis (Bern 1994). 2010 Mar 31;99(7):429-35. doi: 10.1024/1661-8157/a000088. Praxis (Bern 1994). 2010. PMID: 20358518 Review. German.
Cited by
-
Cognitive Impairment Is Independently Associated with Non-Adherence to Antithrombotic Therapy in Older Patients with Atrial Fibrillation.Int J Environ Res Public Health. 2019 Jul 29;16(15):2698. doi: 10.3390/ijerph16152698. Int J Environ Res Public Health. 2019. PMID: 31362337 Free PMC article.
-
Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway.J Am Heart Assoc. 2023 Feb 7;12(3):e028562. doi: 10.1161/JAHA.122.028562. Epub 2023 Feb 7. J Am Heart Assoc. 2023. PMID: 36342828 Free PMC article. Clinical Trial.
-
The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy.Drugs Aging. 2012 Apr 1;29(4):307-17. doi: 10.2165/11599060-000000000-00000. Drugs Aging. 2012. PMID: 22462629
-
Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.J Am Geriatr Soc. 2020 Jan;68(1):147-154. doi: 10.1111/jgs.16178. Epub 2019 Oct 1. J Am Geriatr Soc. 2020. PMID: 31574165 Free PMC article.
-
Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.J Am Heart Assoc. 2019 Jun 4;8(11):e011358. doi: 10.1161/JAHA.118.011358. Epub 2019 May 29. J Am Heart Assoc. 2019. PMID: 31138001 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical